← FDA DRUG APPROVALS

FDA ANDA · ANDA086766

NITROFURAZONE

Sponsor: WENDT

APPLICATION
ANDA086766
TYPE
ANDA
ORIGINAL APPROVAL
1981-05-11
LATEST ACTION
1982-02-17
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

NITROFURAZONEDiscontinued
NITROFURAZONE 0.2% · OINTMENT · TOPICAL

Approval history

1982-02-17Manufacturing (CMC) · Supplement 3AP
1982-02-17Manufacturing (CMC) · Supplement 1AP
1981-05-11OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →